Catabasis Pharmaceuticals Stock Predictions

Healthcare > Biotechnology

Buy CATB

*Your capital is at risk

$3.36

+0.195 (+6.16%)

At Close: May 27, 2022

Currently predicting for Mon, 8 Jun 2026

CATB Prediction Chart

CATB Predictions History

Latest community submissions for CATB.

Predictor	Target Session	Target Price	Result	Direction	Accuracy
Drew.Robertson.4311	Mar 15, 2017	$1.90 +8.57%	$1.75	X	91.40%
GeniusNinja	Mar 13, 2017	$2.46 +47.31%	$1.67	X	52.70%
JS Pro	Mar 13, 2017	$2.42 +44.91%	$1.67	X	55.10%
Jack.Cesario.Migueis.3576 Amateur	Mar 13, 2017	$1.97 +17.96%	$1.67	X	82.00%

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CATB with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT CATABASIS PHARMACEUTICALS

Catabasis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics to treat inflammatory and metabolic diseases. Its product pipeline includes CAT-1004, an oral small molecule that has completed Phase 1 clinical trials for the treatment of duchenne muscular dystrophy (DMD); CAT-2054, which is in Phase I clinical trial for the treatment of hypercholesterolemia i...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
RUN $12.83	4.09%	May 06
GLBE $31.61	1.65%	May 05
SAP $172.39	7.18%	May 05
FIZZ $34.11	7.04%	May 01
ADBE $243.57	3.23%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by